- Country: Panama
- Summary: Methylprednisolone Acetate or Triamcinolone Acetonide or Diacetate: 40Mg/Ml, Solution, Ampoule or Vial, Iml, Intramuscular; Intraarticular, Soft Tissue and Intralesional. Ctni10258. 100081085
- PAT Ref No: 100636613
- Deadline: 06 May 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: PAB 1689.00
- Notice Type: Tender
- Document Ref. No.: 2024-1-10-0-01-LP-531731
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Methylprednisolone Acetate or Triamcinolone Acetonide or Diacetate: 40mg/ml, Solution, Ampoule or Vial, Iml, Intramuscular; Intraarticular, soft tissue and intralesional. Ctni10258. 100081085
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMethylprednisolone Acetate or Triamcinolone Acetonide or Diacetate: 40Mg/Ml, Solution, Ampoule or Vial, Iml, Intramuscular; Intraarticular, Soft Tissue and Intralesional. Ctni10258. 100081085 - Panama Tender
The SOCIAL INSURANCE FUND, a Government sector organization in Panama, has announced a new tender for Methylprednisolone Acetate or Triamcinolone Acetonide or Diacetate: 40Mg/Ml, Solution, Ampoule or Vial, Iml, Intramuscular; Intraarticular, Soft Tissue and Intralesional. Ctni10258. 100081085. This tender is published on PanamaTenders under PAT Ref No: 100636613 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-05-06.
The estimated tender value is PAB 1689.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
